These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
516 related items for PubMed ID: 25891086
1. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice. Gan L, Meng ZJ, Xiong RB, Guo JQ, Lu XC, Zheng ZW, Deng YP, Luo BD, Zou F, Li H. Acta Pharmacol Sin; 2015 May; 36(5):597-605. PubMed ID: 25891086 [Abstract] [Full Text] [Related]
2. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice. Santamarina AB, Carvalho-Silva M, Gomes LM, Okuda MH, Santana AA, Streck EL, Seelaender M, do Nascimento CM, Ribeiro EB, Lira FS, Oyama LM. J Nutr Biochem; 2015 Nov; 26(11):1348-56. PubMed ID: 26300331 [Abstract] [Full Text] [Related]
3. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. Ding Y, Sun X, Chen Y, Deng Y, Qian K. Eur J Pharmacol; 2015 Aug 15; 761():405-12. PubMed ID: 25967348 [Abstract] [Full Text] [Related]
4. Green tea polyphenol epigallocatechin-3-gallate alleviates nonalcoholic fatty liver disease and ameliorates intestinal immunity in mice fed a high-fat diet. Huang J, Li W, Liao W, Hao Q, Tang D, Wang D, Wang Y, Ge G. Food Funct; 2020 Nov 18; 11(11):9924-9935. PubMed ID: 33095225 [Abstract] [Full Text] [Related]
5. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats. Qiu X, Gao DH, Xiang X, Xiong YF, Zhu TS, Liu LG, Sun XF, Hao LP. World J Gastroenterol; 2015 Jul 14; 21(26):8061-72. PubMed ID: 26185377 [Abstract] [Full Text] [Related]
6. Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization. Du Y, Paglicawan L, Soomro S, Abunofal O, Baig S, Vanarsa K, Hicks J, Mohan C. Nutrients; 2021 Feb 11; 13(2):. PubMed ID: 33670347 [Abstract] [Full Text] [Related]
7. Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4. Yang M, Yan R, Sha R, Wang X, Zhou S, Li B, Zheng Q, Cao Y. Clin Nutr; 2024 Aug 11; 43(8):1769-1780. PubMed ID: 38936303 [Abstract] [Full Text] [Related]
8. Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats. Li W, Zhu C, Liu T, Zhang W, Liu X, Li P, Zhu T. Diab Vasc Dis Res; 2020 Aug 11; 17(6):1479164120966998. PubMed ID: 33280417 [Abstract] [Full Text] [Related]
9. Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet. Lee MR, Park KI, Ma JY. Nutrients; 2017 Dec 25; 10(1):. PubMed ID: 29295591 [Abstract] [Full Text] [Related]
10. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice. Cai X, Fang C, Hayashi S, Hao S, Zhao M, Tsutsui H, Nishiguchi S, Sheng J. J Gastroenterol; 2016 Aug 25; 51(8):819-29. PubMed ID: 26794005 [Abstract] [Full Text] [Related]
11. Epigallocatechin-3-Gallate-Rich Green Tea Extract Ameliorates Fatty Liver and Weight Gain in Mice Fed a High Fat Diet by Activating the Sirtuin 1 and AMP Activating Protein Kinase Pathway. Bae UJ, Park J, Park IW, Chae BM, Oh MR, Jung SJ, Ryu GS, Chae SW, Park BH. Am J Chin Med; 2018 Aug 25; 46(3):617-632. PubMed ID: 29595075 [Abstract] [Full Text] [Related]
12. Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation. Mao D, Guo J, Yang K, Yang F, Peng J, Jia X, Luo Z, Liu L, Yang E, Tang R, Lan H, Zheng Q. Biochem Biophys Res Commun; 2024 Nov 19; 734():150424. PubMed ID: 39083974 [Abstract] [Full Text] [Related]
13. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Chen N, Bezzina R, Hinch E, Lewandowski PA, Cameron-Smith D, Mathai ML, Jois M, Sinclair AJ, Begg DP, Wark JD, Weisinger HS, Weisinger RS. Nutr Res; 2009 Nov 19; 29(11):784-93. PubMed ID: 19932867 [Abstract] [Full Text] [Related]
14. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice. Song H, Chu Q, Yan F, Yang Y, Han W, Zheng X. J Gastroenterol Hepatol; 2016 Aug 19; 31(8):1462-9. PubMed ID: 26699443 [Abstract] [Full Text] [Related]
15. Green Tea Polyphenol EGCG Alleviates Metabolic Abnormality and Fatty Liver by Decreasing Bile Acid and Lipid Absorption in Mice. Huang J, Feng S, Liu A, Dai Z, Wang H, Reuhl K, Lu W, Yang CS. Mol Nutr Food Res; 2018 Feb 19; 62(4):. PubMed ID: 29278293 [Abstract] [Full Text] [Related]
16. Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats. Yang Z, Zhu MZ, Zhang YB, Wen BB, An HM, Ou XC, Xiong YF, Lin HY, Liu ZH, Huang JA. Phytother Res; 2019 Apr 19; 33(4):1019-1026. PubMed ID: 30746789 [Abstract] [Full Text] [Related]
17. Decaffeinated green tea extract rich in epigallocatechin-3-gallate improves insulin resistance and metabolic profiles in normolipidic diet--but not high-fat diet-fed mice. Santana A, Santamarina A, Souza G, Mennitti L, Okuda M, Venancio D, Seelaender M, do Nascimento CO, Ribeiro E, Lira F, Oyama L. J Nutr Biochem; 2015 Sep 19; 26(9):893-902. PubMed ID: 26048201 [Abstract] [Full Text] [Related]
18. Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats. Hou H, Yang W, Bao S, Cao Y. J Oleo Sci; 2020 May 02; 69(5):479-486. PubMed ID: 32281563 [Abstract] [Full Text] [Related]
19. Therapeutic effects of globular adiponectin in diabetic rats with nonalcoholic fatty liver disease. Ma H, Cui F, Dong JJ, You GP, Yang XJ, Lu HD, Huang YL. World J Gastroenterol; 2014 Oct 28; 20(40):14950-7. PubMed ID: 25356056 [Abstract] [Full Text] [Related]